| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.5 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |